Observe the comparative effect of the khadirarishta if we make it in two different seasons, one in Greeshma and another in Sharad Ritu in the patients of Dadru Kushtha.

A comparative Pharmaceutical & Analytical study of Khadirarishta prepared in Greeshma & Sharad ritu and its clinical effects in Dadru - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056297

Enrollment

Registered

2023-08-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Disease presenting with classical clinical features of Dadru- itching, erythema, eruptions, elevated circular skin lesion 2.Positive KOH test for Taenia corporis and Taenia cruris 3.Patients having history within one month or less than one month of origin.

Exclusion criteria

Exclusion criteria: 1.Patients having age group of less than 16 years and 70 years . 2.Patients having complain for more than one month. 3.Other types of Kushtha & skin disease except for Dadru kushtha, Taenia corporis, Taenia cruris. 4.Patients with chronic cases, hypertension, diabetes mellitus, pregnant & Lactating women etc. 5.Patients having treatment with systemic antifungal and local antiseptic or other treatment 6.If any adverse effect is observed in patients after consuming Khadirarishta. 7.If patients do not follow advices.

Design outcomes

Primary

Measure	Time frame
cure the disease completelyTimepoint: 28 days	—

Secondary

Measure	Time frame
Relief in symptomsTimepoint: Follow up after 7 days, 14 days, 21 days, 28 days	—

Countries

India

Contacts

Public ContactDr Vijay Kumar Rai

Government Ayurvedic College, Chaukaghat, Varanasi, UTTAR PRADESH, 221002

drankitg01@gmail.com9532016160

Outcome results